| Beyond informed consent: the therapeutic misconception and trust I de Melo-Martin, A Ho Journal of medical ethics 34 (3), 202-205, 2008 | 139 | 2008 |
| The fight against doubt: How to bridge the gap between scientists and the public I de Melo-Martín, K Intemann Oxford University Press, 2018 | 130 | 2018 |
| The Ethics of Anonymous Gamete Donation: Is There a Right to Know One's Genetic Origins? ID Melo‐Martín Hastings center report 44 (2), 28-35, 2014 | 96 | 2014 |
| The role of ethics in shale gas policies I de Melo-Martín, J Hays, ML Finkel Science of the total environment 470, 1114-1119, 2014 | 79 | 2014 |
| On our obligation to select the best children: a reply to Savulescu I De Melo‐Martín Bioethics 18 (1), 72-83, 2004 | 73 | 2004 |
| The risk of using inductive risk to challenge the value-free ideal I de Melo-Martín, K Intemann Philosophy of Science 83 (4), 500-520, 2016 | 66 | 2016 |
| Eugenics S Goering Stanford Encyclopedia of Philosophy 2, 2014 | 63* | 2014 |
| On cloning human beings I De Melo‐Martín Bioethics 16 (3), 246-265, 2002 | 62 | 2002 |
| Clinical and Translational Science Awards: can they increase the efficiency and speed of clinical and translational research? C Heller, I de Melo-Martín Academic Medicine 84 (4), 424-432, 2009 | 59 | 2009 |
| Rethinking reprogenetics: Enhancing ethical analyses of reprogenetic technologies I de Melo-Martín Oxford University Press, 2016 | 57 | 2016 |
| Moral bioenhancement: much ado about nothing? I de Melo‐Martin, A Salles Bioethics 29 (4), 223-232, 2015 | 56 | 2015 |
| Interpreting evidence: why values can matter as much as science I de Melo-Martín, K Intemann Perspectives in biology and medicine 55 (1), 59-70, 2012 | 55 | 2012 |
| Developing a research ethics consultation service to foster responsive and responsible clinical research I de Melo-Martín, LI Palmer, JJ Fins Academic Medicine 82 (9), 900-904, 2007 | 51 | 2007 |
| How do disclosure policies fail? Let us count the ways I de Melo-Martín, K Intemann The FASEB Journal 23 (6), 1638-1642, 2009 | 48 | 2009 |
| Patenting and the gender gap: Should women be encouraged to patent more? I de Melo-Martín Science and engineering ethics 19, 491-504, 2013 | 46 | 2013 |
| The promise of the human papillomavirus vaccine does not confer immunity against ethical reflection I de Melo-Martin The Oncologist 11 (4), 393-396, 2006 | 43 | 2006 |
| Beyond risk: A more realistic risk–benefit analysis of agricultural biotechnologies I de Melo‐Martín, Z Meghani EMBO reports 9 (4), 302-306, 2008 | 42 | 2008 |
| Moral distress: What are we measuring? L Kolbe, I de Melo-Martin The American Journal of Bioethics 23 (4), 46-58, 2023 | 40 | 2023 |
| Social values and scientific evidence: the case of the HPV vaccines K Intemann, I de Melo-Martín Biology & philosophy 25, 203-213, 2010 | 38 | 2010 |
| Defending human enhancement technologies: Unveiling normativity I de Melo-Martín Journal of Medical Ethics 36 (8), 483-487, 2010 | 36 | 2010 |
